La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Getinge Gestion

Gestion contrôle des critères 3/4

Le PDG Getinge's est Mattias Perjos, nommé en Mar2017, a un mandat de 7.42 ans. La rémunération annuelle totale est SEK 46.39M, composée du salaire de 55.9% et des bonus 44.1%, y compris les actions et options de la société. détient directement 0.029% des actions de la société, d'une valeur de SEK 16.27M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.8 ans et 7.4 ans.

Informations clés

Mattias Perjos

Directeur général

SEK 46.4m

Rémunération totale

Pourcentage du salaire du PDG	55.9%
Durée du mandat du directeur général	7.4yrs
Propriété du PDG	0.03%
Durée moyenne d'occupation des postes de direction	4.8yrs
Durée moyenne du mandat des membres du conseil d'administration	7.4yrs

Mises à jour récentes de la gestion

Recent updates

An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued

Aug 08

Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 21

We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)

Jun 27

Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly

May 11

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Apr 25

Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?

Apr 15

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Mar 30

Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Mar 29

The Return Trends At Getinge (STO:GETI B) Look Promising

Mar 21

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Feb 04

There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price

Jan 20

Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly

Jan 05

Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price

Dec 20

Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)

Dec 05

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Oct 06

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?

Sep 21

Getinge's (STO:GETI B) Returns On Capital Are Heading Higher

Sep 03

Is Getinge (STO:GETI B) A Risky Investment?

Jun 28

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?

Jun 15

Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist

Jun 01

At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?

May 05

Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Apr 05

Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement

Feb 28

Analyse de la rémunération des PDG

Comment la rémunération de Mattias Perjos a-t-elle évolué par rapport aux bénéfices de Getinge?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	SEK 3b
Mar 31 2024	n/a	n/a	SEK 2b
Dec 31 2023	SEK 46m	SEK 26m	SEK 2b
Sep 30 2023	n/a	n/a	SEK 2b
Jun 30 2023	n/a	n/a	SEK 2b
Mar 31 2023	n/a	n/a	SEK 3b
Dec 31 2022	SEK 43m	SEK 24m	SEK 2b
Sep 30 2022	n/a	n/a	SEK 3b
Jun 30 2022	n/a	n/a	SEK 3b
Mar 31 2022	n/a	n/a	SEK 3b
Dec 31 2021	SEK 60m	SEK 23m	SEK 3b
Sep 30 2021	n/a	n/a	SEK 3b
Jun 30 2021	n/a	n/a	SEK 4b
Mar 31 2021	n/a	n/a	SEK 4b
Dec 31 2020	SEK 67m	SEK 23m	SEK 3b
Sep 30 2020	n/a	n/a	SEK 3b
Jun 30 2020	n/a	n/a	SEK 2b
Mar 31 2020	n/a	n/a	SEK 1b
Dec 31 2019	SEK 46m	SEK 22m	SEK 1b
Sep 30 2019	n/a	n/a	SEK 1b
Jun 30 2019	n/a	n/a	-SEK 632m
Mar 31 2019	n/a	n/a	-SEK 654m
Dec 31 2018	SEK 34m	SEK 21m	-SEK 967m
Sep 30 2018	n/a	n/a	-SEK 727m
Jun 30 2018	n/a	n/a	SEK 847m
Mar 31 2018	n/a	n/a	SEK 676m
Dec 31 2017	SEK 26m	SEK 15m	SEK 1b

Rémunération vs marché: La rémunération totale de Mattias ($USD 4.55M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Swedish ($USD 2.38M ).

Rémunération et revenus: La rémunération de Mattias a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Mattias Perjos (52 yo)

7.4yrs

Titularisation

SEK 46,388,000

Compensation

Mr. Mattias Perjos, M. Sc., serves as Independent Director at Euroapi S. A. since January 11, 2023. He has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serv...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Mattias Perjos	CEO, President & Director	7.4yrs	SEK 46.39m	0.029% SEK 16.3m
Agneta Palmer	Chief Financial Officer	less than a year	pas de données	pas de données
Lars Mattsson	Head of Investor Relations	no data	pas de données	pas de données
Anna Romberg	Executive Vice President of Sustainability	3.8yrs	pas de données	0.0020% SEK 1.1m
Magnus Lundback	Executive Vice President of Human Resources	7.6yrs	pas de données	0.0014% SEK 781.1k
Carsten Blecker	Chief Commercial Officer	6.7yrs	pas de données	0.0018% SEK 1.0m
Stephane Roy	President of Surgical Workflows	5.8yrs	pas de données	0.0014% SEK 775.6k
Eric Honroth	President of Life Science	no data	pas de données	0.000060% SEK 33.2k
Patricia Fitch	President of North America Region	2.3yrs	pas de données	pas de données
Elin Frostehav	President of Acute Care Therapies	2.3yrs	pas de données	0.00032% SEK 177.3k
Joanna Engelke	Executive VP of Quality Compliance	1.8yrs	pas de données	pas de données
Avril Forde	President of Maquet Ltd & Maquet Ireland	8.6yrs	pas de données	pas de données

4.8yrs

Durée moyenne de l'emploi

52yo

Âge moyen

Gestion expérimentée: L'équipe de direction de GETI B est considérée comme expérimentée (ancienneté moyenne 4.8 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Mattias Perjos	CEO, President & Director	7.4yrs	SEK 46.39m	0.029% SEK 16.3m
Johan Bygge	Independent Director	17.3yrs	SEK 972.90k	0.0058% SEK 3.2m
Carl Bennet	Non-Independent Vice Chairman	35.6yrs	SEK 781.43k	pas de données
Malin Persson	Independent Director	10.6yrs	SEK 781.43k	0.0030% SEK 1.7m
Johan Malmquist	Independent Chairman	8.4yrs	SEK 1.73m	0.037% SEK 20.3m
Cecilia Wennborg	Independent Director	14.3yrs	SEK 969.80k	0.0029% SEK 1.6m
Ake Larsson	Employee Representative Director	1.8yrs	pas de données	pas de données
Dan Frohm	Non-Independent Director	7.4yrs	SEK 928.40k	0.055% SEK 30.4m
Fredrik Brattborn	Employee Representative Director	2.3yrs	pas de données	pas de données
Kristian Samuelsson	Independent Director	3.3yrs	SEK 819.72k	pas de données
Pontus Kall	Deputy Director	no data	pas de données	pas de données
Ida Gustafsson	Deputy Director	1.8yrs	pas de données	0.000020% SEK 11.1k

7.4yrs

Durée moyenne de l'emploi

54yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de GETI B sont considérés comme expérimentés (ancienneté moyenne 7.4 ans).

Getinge Gestion

Gestion contrôle des critères 3/4

Informations clés

Mises à jour récentes de la gestion

Getinge Announces CFO Changes

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Getinge AB (Publ) Announces Executive Changes

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team

Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs

Recent updates

An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued

Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Getinge AB (publ) to Report Q2, 2024 Results on Jul 18, 2024

We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)

Investor sentiment deteriorates as stock falls 18%

Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Getinge AB (publ) Declares A Dividend, Payable on 29 April 2024

Upcoming dividend of kr4.40 per share

Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Getinge AB (publ) to Report Fiscal Year 2024 Results on Jan 28, 2025

The Return Trends At Getinge (STO:GETI B) Look Promising

Dividend increased to kr4.40

Getinge AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Getinge AB (Publ) Proposes Dividend, Payable on April 29, 2024

Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Getinge AB (Publ) Provides Sales Guidance for the Year 2024

Getinge Announces CFO Changes

There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price

Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly

Price target increased by 8.4% to kr229

Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price

Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)

Price target increased by 7.0% to kr220

Consensus EPS estimates increase by 23%

Third quarter 2023 earnings: Revenues exceed analyst expectations

Getinge AB (publ) (OM:GETI B) acquired Healthmark Industries Company, Inc. for $320 million.

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Getinge's (STO:GETI B) Returns On Capital Are Heading Higher

Second quarter 2023 earnings: Revenues exceed analyst expectations

Getinge Receives US FDA 510(K) Clearance for Servo-Air® Lite

Is Getinge (STO:GETI B) A Risky Investment?

Consensus EPS estimates fall by 13%

Investor sentiment deteriorates as stock falls 22%

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?

Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire High Purity New England Inc. for approximately $290 million.

Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist

At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?

First quarter 2023 earnings: Revenues exceed analyst expectations

Now 22% undervalued

Upcoming dividend of kr4.25 per share at 1.6% yield

Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement

Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?

Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year

Getinge Provides Financial Guidance for the First Half, Second Half and Full Year of 2023

Is Getinge (STO:GETI B) Using Too Much Debt?

Full year 2022 earnings: EPS misses analyst expectations

Getinge AB (Publ) Proposes Dividend

Price target decreased to kr249

When Should You Buy Getinge AB (publ) (STO:GETI B)?

Price target decreased to kr272

U.S. Food and Drug Administration Broadens the Consent Decree with Getinge and Includes Its Subsidiary Datascope

Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 49%?

Third quarter 2022 earnings: Revenues in line with analyst expectations

Getinge AB (publ) Provides Sales Guidance for the Full Year 2022

Getinge AB (Publ) Announces Executive Changes

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Price target decreased to kr293

Getinge AB (Publ) Announces Medical Device Field Action of Hls Set Advanced Products